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ton UniversityObjective: Previous studies have shown social support to be inversely associated with cardiovascular disease
(CVD) in men, whereas fewer studies have assessed the relationship in women. The purpose of this study was to
evaluate the relationship between perceived social support and cardiovascular outcomes among postmenopausal
women enrolled in the Women’s Health Initiative Observational Study.
Methods: We examined the relationships between perceived social support and (1) incident coronary heart
disease (CHD), (2) total CVD, and (3) all-cause mortality. Participants were Women’s Health Initiative Observa-
tional Study women, ages 50 to 79 years, enrolled between 1993 and 1998 and followed for up to 10.8 years. Social
support was ascertained at baseline via nine questions measuring the following functional support components:
emotional/informational, tangible, positive social interaction, and affectionate support.
Results: Among women with prior CVD (n¼ 17,351) and no prior CVD (n¼ 73,421), unadjusted hazard ratios
ranged from 0.83 to 0.93 per standard deviation increment of social support. Adjustment for potential
confounders, such as smoking and physical activity levels, eliminated the statistical significance of the
associations with CHD and CVD. However, for all-cause mortality and among women free of baseline CVD,
the association was modest but remained statistically significant after this adjustment (hazard ratio¼ 0.95 [95%
confidence interval, 0.91-0.98]). No statistically significant association was observed among women with a
history of CVD.
Conclusions: After controlling for potential confounding variables, higher perceived social support is not
associated with incident CHD or CVD. However, among women free of CVD at baseline, perceived social support is
associated with a slightly lower risk of all-cause mortality.
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mortality have declined in the past few decades, yet
CVD still remains a primary cause of death in
Americans, resulting in approximately one third of all deaths.1
Traditionally, more men than women were diagnosed with
CVD, but in recent years, women’s rates of CVD haveust 2, 2018; revised and accepted November 12, 2018.
partment of Health Administration and Policy, George 
rsity, Fairfax, VA; 2Department of Epidemiology and 
ilken Institute School of Public Health, George Wash-
sity, Washington, DC; 3Division of Preventive Medicine 
omen’s Hospital, Professor of Medicine, Harvard Medi-
oston, MA; 4Senior Scientist, Medstar Health Research 
hington, DC; 5Department of Medicine, Division of Gen-
edicine, University of North Carolina, Chapel Hill, NC;
of Family Medicine and Public Health, University of 
 Diego, San Diego, CA; 7Department of Social Medicine, 
 Medicine, University of North Carolina School of Medi-
ill, NC; 8University of Hawaii, Honolulu, HI; 9Department 
 University of Iowa, Iowa City, IA; and 10Division of 
chool of Medicine and Health Sciences, George Washing-
, Washington, DC.have CVD vs 37.4% of men). Researchers have predomi-
nantly assessed the influence of traditional risk factors such as
smoking and hypertension on CVD, but evidence that psy-
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have moderate risks for developing CVD, establishing addi- support is confounded by need and used less frequently.
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FIG. 1. Overview of social support and related concepts. Cohen S, Underwood LG, Gottlieb BH eds. Social Support Measurement and Intervention: A
Guide for Social Scientists. New York: Oxford University Press; 2000. Related concepts may function as antecedents or consequences of social support
or both, or may be correlated with social support types for other reasons.tional prevention efforts will be helpful.
Over the last three decades, greater scientific attention has
been given to the relationship between psychosocial factors
and health, particularly cardiovascular health, yet the rela-
tionship between social support and CVD needs further
elucidation. Risk factors that have a social element, such
as loneliness, or a psychological element, such as depression,
are associated with disease such as CVD4,5; breast cancer
recurrence6; symptoms7,8; health behaviors9,10; and mortal-
ity.11-13 Psychosocial factors association with CVD have been
found14-19 and psychosocial interventions have been sug-
gested as adjuvant to more traditional treatments such as
medical management and health behavior change efforts.2,3
There are multiple views and measures of social support.20
Typically, social support has been conceived as (1) the
network of people connected to an individual (structural
support) or (2) the resources available to an individual, such
as help with a chore (functional support).20,21 Social networks
or ties have been associated with health22 and mortality23 and
pertaining to this study, related to CVD risk factors,24-26
incident or prevalent CVD,27,28 or mortality from
CVD.19,29 Both structural support and functional support have
been found to have associations with health outcomes. Func-
tional social support, the type of support used in this research,
is generally theorized to affect health by either promoting
stress relief by buffering stressful life events20,30-32 (stress
coping perspective) or by affecting self-esteem which can
lead to better health behaviors (social constructionist or social
cognitive model).33,34 According to the stress coping perspec-
tive, an individual’s appraisal of a situation affects the rela-
tionship between stress and health. Some research has focused
on perceived social support,11,35-38 whereas other studies have
used measures of received functional support.39-41 ReceivedFigure 1 presents a typical view in the social support literature
of how social support has been conceptualized for
research studies.
Individuals with higher levels of social support have a
lower risk for developing CVD36-38,42-44 and those who have a
history of CVD, who have higher levels of support, have
better health outcomes.11,45-48
In addition, studies have suggested that social support is
inversely associated with mortality23,28 and while the associa-
tion is established, no large-scale studies have been done in
postmenopausal women. Early studies investigating perceived
social support’s association with CVD were done only in
men.36,38,42 More recently, both women and men were studied.
However, in studies in both populations, the effect size was
larger men,43,49 women,46 or different in men than in women,37
which indicates continued study of social support’s effect on
CVD and mortality in women is warranted. Notably, many of
the former studies used significantly smaller cohorts.36-38,42
Despite there being a large body of research showcasing
evidence of association of social ties to CVD, only a few
studies used the social support measure of perceived support,
instead using measures of structural support—social network
scores or social ties.27,29 Therefore, further study of the rela-
tionship between perceived social support and CVD will help
elucidate if the relatively strong association between functional
social support and CVD in men is similar to that in women, and
will help clarify whether lack of social support affects cardio-
vascular and overall mortality in postmenopausal women.
The purpose of this investigation was to assess perceived
social support and its relationship to CVD or all-cause mor-
tality in this large racially diverse cohort of postmenopausal
women in the Women’s Health Initiative Observational Study
(WHI-OS).
assistance’’); (4) positive social interaction (‘‘the availabilityMETHODSStudy design and participants
The WHI study design has been previously described in 
detail.50 Investigators planned for a prospective observational 
study of postmenopausal women to assess health risks and 
disease prevention longitudinally. WHI recruited more than 
160,000 US women at 40 clinical centers between the ages of 
50 and 79 years between 1993 and 1998 into 1 of 3 clinical 
trials or into the observational study. At the time of enroll-
ment, baseline data were collected including physical mea-
sures such as blood pressure. Participants self-reported on 
their medical and psychological histories and answered mul-
tiple behavioral and psychological questions. Adjudicated 
health outcomes51 were available for women followed up 
to 10.8 years. Women who were not interested in or eligible to 
be in the clinical trial, in which dietary modification, hormone 
therapy, and/or calcium/vitamin D were being investigated, 
were asked to be a part of the observational study. General 
exclusions for participating in the WHI-OS were (1) not 
planning to live in the area for more than 3 years; (2) low 
likelihood of living for longer than 3 years; and (3) certain 
chronic diseases such as dementia or alcohol/drug depen-
dency that would make participation difficult.52 The cohort of 
93,676 women52,53 was 83.3% White, 8.2% Black, 3.9%
Hispanic, and 2.9% Asian/Pacific and as such is considered 
ethnically and racially diverse. After excluding 961 women 
missing either the social support measure or adjudicated 
outcomes, the analysis sample for this study consisted of 
92,715 women. An additional 1,943 women were excluded 
from analyses which stratified by prior CVD because of 
missing data on that variable.
Demographic measures
Demographic data including age, race, education, family 
income, and marital status were measured by self-report using 
questionnaires at baseline.50 Education was categorized from 
0 to 8 years to college degree or higher. Participants indicated 
their family income as ranging from less than $10,000 to more 
than $75,000 per year. Marital status categories were (1) never 
married, (2) divorced/separated, (3) widowed, or (4) presently 
married/living as married.
Psychosocial measures
Nine support items that assessed perception of functional 
support were selected from the 19-item Medical Outcomes 
Study Social Support Survey (MOS-SSS).54 Sherbourne and 
Stewart54 devised the MOS-SSS, which was well-informed by 
theory and determined to be easy to administer, to assess 
social support in persons that are chronically ill. Investigators 
focused on the measurement of perceived availability of 
functional support. The MOS-SSS was developed to assess 
five dimensions of support: (1) emotional (‘‘the expression of 
positive affect; empathetic understanding; and the encourage-
ment of expressions and feelings’’); (2) informational (‘‘the 
offering of advice, information, guidance or feedback’’); (3) 
tangible (‘‘‘‘‘‘‘‘the provision of material aid or behavioralof other persons to do fun things with you’’); and (5)
affectionate support (‘‘involving love and affection’’). Each
of nine questions used in WHI asked participants to rank
support from 1 to 5 on a Likert scale, where 1 was ‘‘none of
the time’’ to 5 ‘‘all of the time’’.55 A sample question reads:
‘‘How often is each of the following kinds of support avail-
able to you if you need it?: ‘‘Someone to have a good time
with’’ (measuring positive social interaction).54 Because the
WHI used only nine questions, there were too few items to
produce highly reliable subscale scores for each dimension.
Therefore, a total summary score of perceived social support
was used instead. The summary score ranged from 9 to 45,
where the higher score corresponds to higher social support.
Other WHI studies have used the social support measure.55,56
We found a coefficient alpha reliability of 0.93 in our sample,
indicating high internal consistency. For testing statistical
associations, we used social support as a continuous variable,
but for descriptive purposes, to help convey magnitudes of
association, we categorized social support in tertiles.
Health behavior and dietary measures
Health behaviors and dietary measures were assessed via
self-report questionnaires. Smoking was categorized as never,
past, or current. Alcohol intake was measured by asking
participants how many servings they had per week. Partic-
ipants were asked about the level of their walking and
physical activity (quantified as mild, moderate, or strenuous).
These responses were then translated into total Metabolic
Equivalent of Task score for each week and were reported in
quintiles. Dietary measures were the following: percentage
saturated fat, percentage trans saturated fat, percentage sugar,
and daily fruits and vegetables, all measured by a food
frequency questionnaire.57
Additional covariates
Physical measurements included body mass index (BMI)
and waist and hip circumferences for the waist to hip ratio and
were assessed by clinical staff at baseline. Hormone therapy
status was measured via questions asking about former and
current hormone therapy use at baseline. Age at menopause
which was estimated by age at last menstrual period or age at
which last ovary was removed (indicating surgical meno-
pause).
Ascertainment of endpoints
The primary outcomes for this study were (1) incident
coronary heart disease (CHD), defined as myocardial infarc-
tion (MI) and/or death from CHD; (2) incident total CVD,
defined as MI, stroke, or death caused by definite or possible
CHD, cerebrovascular disease, or other CVD; and (3) all-
cause mortality which includes CVD mortality, cancer mor-
tality, and non-CVD, noncancer mortality. Cardiovascular
outcomes were adjudicated at local sites by investigators
after review of semiannual self-administered medical history
questionnaires and diagnoses were assigned at the local
level.51 Myocardial infarction was established after physician support. A higher percentage of participants in the lower
review of questionnaires and subsequent medical record
confirmation of electrocardiogram changes, elevated cardiac
enzyme or troponin levels, or both. Stroke was documented in
participants who suffered a neurological deficit appearing to
have been related to a disruption of the brain arterial system,
lasting more than 24 hours. Adjudicators assigned CHD as
cause of death when CHD was specified on death certificate or
autopsy report. Investigators used the National Death Index
and follow-up was provided by family members regarding
death status.51
Statistical analysis
Cox proportional hazards regression models were used to
evaluate the relationships between social support and each of
the three study outcomes. Social support was assessed as a
continuous variable despite being categorized in tertiles for
presentation. Time until each outcome was calculated by
subtracting date of enrollment in the study from the event date
or last day of follow-up. For models predicting the two cardio-
vascular outcomes, incident CHD, and incident total CVD,
participants not experiencing either outcome were coded as
censored when they were last observed to be alive. Martindale
residual plots were used to assess the proportional hazard and
linearity assumptions of social support for each outcome.
For each outcome, a Cox regression model was estimated
first with social support as the sole predictor, followed by a
model adding the following covariates to address potential
confounding: age, education, race, income, and marital status,
and select CVD risk factors (BMI, waist/hip ratio, smoking,
physical activity, alcohol, hormone therapy, age at meno-
pause, percentage saturated fat intake, percentage trans-satu-
rated fat intake, percentage sugar intake, and fruit/vegetable
intake). These well-established sociodemographic and behav-
ioral factors are known to be determinants of CVD and all-
cause mortality. All covariates were selected a priori; no data-
driven model selection approaches were employed. The sam-
ple was stratified by whether the participant reported a history
of CVD before study enrollment.
To facilitate the interpretation of hazard ratios (HRs), social
support was transformed to have a standard deviation of 1.0 in
the full sample. One standard deviation corresponds to 7.92
points, and the scale ranges from 9 to 45. Therefore, for
example, a change from 9 points to 16.92 points for social
support would correspond to a one standard deviation differ-
ence. All analyses were conducted using SAS statistical
software, Version 9.3 (SAS Institute, Cary, NC).
RESULTS
The baseline characteristics of participants in the total
sample (n¼ 92,715) and by perceived social support tertile
categories are presented in Table 1 (see also Table, Supple-
mental Digital Content 1 [http://links.lww.com/MENO/
A373], which shows detailed descriptions of participant
characteristics and outcome events by social support level).
Unadjusted incident CHD was higher in those with lowersupport group were diagnosed with CVD during the course
of the study as compared to those reporting high support.
Similarly, a higher percentage of those in the low support
group died as compared to those in the high support group.
Of the potential confounding variables, income and marital
status showed the strongest association with social support.
For example, 27% of the women in the highest tertile of social
support reported incomes greater than $75,000 a year, as
compared to 13% of women in the lowest tertile of support.
Women in the highest tertile of social support were likely to
be married (78%). Of these women reporting higher support,
19% were divorced while out of the women in the lower
support tertile, 50% were divorced. Of those in the lowest
tertile of support, 10% were black and 5% Hispanic/Latino as
compared to 6% and 3%, respectively of the women in the
higher tertile of support. Participants in the lowest tertile of
support were more likely to have high BMIs—29% of women
with BMI higher than 30 reported low support, whereas just
22% of those in the higher tertile of support had BMIs of more
than 30. Participants in the higher tertile of support tended to
have slightly higher educational attainment and were more
likely to have indicated stronger emotional wellbeing. Those
in the highest tertile of support scored on average 84 out of
100 points on the emotional wellbeing scale, whereas those in
the lower tertile of support scored 72 points (P< 0.0001).
Prediction of outcomes
During the 10.8 years of follow-up in the 92,715 women,
there were 2,060 cases of incident CHD (1,200 without prior
CVD, and 850 with prior CVD). Total CVD cases were 4,440
(2,730 without prior CVD, and 1,710 with prior CVD). Cases
of all-cause mortality were 6,029 (4,030 without prior CVD,
and 1,999 with prior CVD).
Cox regression analyses were done separately for women
with and without self-reported CVD at baseline (Table 2).
Because 1,943 women had missing data on prior CVD, they
were excluded from these analyses. Among women without
prior CVD, who were the majority of the cohort (n¼ 73,421),
the unadjusted HR for incident CHD per one standard deviation
increase in social support was 0.92 (95% confidence interval
[CI], 0.87-0.97), indicating an estimated decrease in risk of
incident heart disease of 8% for each standard deviation
increase in social support. For total CVD, the HR was 0.86
(95% CI, 0.83-0.89), whereas for overall mortality the risk was
0.83 (95% CI, 0.81-0.86). When adjusted for potential con-
founders, the associations were substantially attenuated. For
example, for incident CHD and total CVD, the HRs were 0.99
(95% CI, 0.93-1.06) and 0.96 (95% CI, 0.92-1.00), respec-
tively. For all-cause mortality, the relationship attenuated to
0.95, but remained statistically significant (CI, 0.91-0.98).
Among women with prior CVD, the unadjusted HR for
incident CHD per one standard deviation increase in social
support was 0.93 (CI, 0.88-1.00), whereas for total CVD the
unadjusted HR was 0.91 (95% CI, 0.87, 0.95). The all-cause
mortality unadjusted HR was 0.88 (95% CI, 0.85, 0.92). All of
Perceived social support tertile
Total sampleLow (9-33) Middle (34-40) High (41-45)
Participants, na 30,394 31,077 31,244 92,715
Self-reported cardiovascular disease prior to study entry, n (%)
No 23,318 (79) 24,748 (81) 25,355 (83) 73,421 (81)
Yes 6,332 (21) 5,735 (19) 5,285 (17) 17,351 (19)
Unknown 744 594 605
Diagnosed with cardiovascular disease after study entry, n (%)
No 28,596 (94) 29,622 (95) 29,931 (96) 88,149 (95)
Yes 1,798 (6) 1,455 (5) 1,313 (4) 4,566 (5)
Diagnosed with CHD (MIb or death from coronary causes) after study entry, n (%)
No 29,439 (97) 30,306 (98) 30,512 (98) 90,257 (97)
Yes 955 (3) 771 (2) 732 (2) 2,458 (3)
Died (all cause), n (%)
No 27,895 (92) 29,132 (94) 29,479 (94) 86,506 (93)
Yes 2,499 (8) 1,945 (6) 1,765 (6) 6,209 (7)
Age at screening
Mean (SD) 64.2 (7.5) 63.4 (7.3) 63.3 (7.2) 63.6 (7.4)
Unknown 1 4 1
Education, n (%)
No HS diploma or GED 2,076 (7) 1,404 (5) 1,213 (4) 4,693 (5)
HS diploma or GED 4,889 (16) 4,803 (16) 5,260 (17) 14,952 (16)
Some college or degree 14,643 (49) 14,712 (48) 14,823 (48) 44,178 (48)
Some post-graduate or degree 8,524 (28) 9,896 (32) 9,722 (31) 28,142 (31)
Unknown 262 262 226
Race, n (%)
American Indian or Alaskan Native 181 (0.6) 131 (0.4) 98 (0.3) 410 (0.4)
Asian or Pacific Islander 899 (3) 950 (3) 787 (3) 2,636 (3)
Black or African-American 2,960 (10) 2,502 (8) 2,004 (6) 7,466 (8)
Hispanic/Latino 1,559 (5) 987 (3) 908 (3) 3,454 (4)
White (not of Hispanic origin) 24,258 (80) 26,110 (84) 27,087 (87) 77,455 (84)
Other or unknownc 537 397 360
Income, n (%)
<$20,000 6,943 (25) 3,957 (14) 2,846 (10) 13,746 (16)
$20,000-$34,999 7,710 (27) 6,645 (22) 5,682 (19) 20,037 (23)
$35,000-$74,999 9,990 (35) 12,154 (42) 12,538 (43) 34,682 (40)
$75,000þ 3,505 (13) 6,187 (21) 7,816 (27) 17,508 (20)
Do not know or unknownd 2,246 2,134 2,362
Marital status, n (%)
Never married 2,065 (7) 1,445 (5) 827 (3) 4,337 (5)
Divorced, separated or widowed 15,113 (50) 9,677 (31) 5,782 (19) 30,572 (33)
Married or cohabiting 13,044 (43) 19,800 (64) 24,521 (78) 57,365 (62)
Unknown 172 155 114
Body mass index, n (%)
<25.0 11,283 (38) 12,927 (42) 13,282 (43) 37,492 (41)
25.0-29.9 10,080 (34) 10,350 (34) 10,710 (35) 37,492 (34)
30 or more 8,649 (29) 7,455 (24) 6,896 (22) 23,000 (25)
Unknown 382 345 356
Waist/hip ratio
Mean (SD) 0.815 (0.08) 0.804 (0.08) 0.801 (0.08) 0.81 (0.08)
Unknown 170 176 156
Smoking status, n (%)
Never smoked 14,592 (49) 15,675 (51) 16,336 (53) 46,603 (51)
Past smoker 12,957 (43) 13,219 (43) 13,041 (42) 39,217 (43)
Current smoker 2,356 (8) 1,809 (6) 1,548 (5) 5,713 (6)
Unknown 489 374 319
METSe per week, n (%)
<7 13,471 (45) 11,932 (39) 11,116 (36) 36,519 (40)
7 Or more 16,606 (55) 18,863 (61) 19,831 (64) 55,300 (60)
Unknown 317 282 297
Alcohol servings per week
Mean (SD) 2.20 (6.1) 2.54 (5.1) 2.77 (5.3) 2.51 (5.2)
Unknown 82 66 55
Hormone therapy, n (%)
Never used hormones 9,828 (33) 8,934 (29) 8,954 (29) 27,716 (30)
Past hormone user 6,847 (23) 6,448 (21) 5,987 (20) 19,282 (21)
Current hormone user 13,202 (44) 15,157 (50) 15,700 (51) 44,059 (48)
Unknown 517 538 603
(Continued on next page )
TABLE 1. Participant characteristics and outcome events by social support level
these results became nonsignificant when adjusted for con- In order to explore which of the potential confounders may
Perceived social support tertile
Total sampleLow (9-33) Middle (34-40) High (41-45)
Early menopause, n (%)
No 20,055 (70) 21,546 (72) 21,737 (72) 63,338 (71)
Yes 8,790 (31) 8,341 (28) 8,403 (28) 25,534 (29)
Unknown 1,549 1,190 1,104
Percent calories from saturated fatty acid
Mean (SD) 10.2 (3.4) 10.0 (3.3) 9.8 (3.3) 10 (3.3)
Unknown 1,497 1,044 1,057
Dietary total trans fatty acid, g
Mean (SD) 3.9 (2.9) 3.8 (2.7) 3.6 (2.6) 3.8 (2.8)
Unknown 1,497 1,044 1,057
Dietary total sugars, g
Mean (SD) 100.5 (47.8) 99.9 (44.3) 99.4 (44) 99.9 (45.4)
Unknown 1,497 1,044 1,057
Fruits and vegetables, median servings/day
Mean (SD) 4.2 (2.2) 4.4 (2.2) 4.5 (2.2) 4.4 (2.2)
Unknown 1,497 1,044 1,057
Parent with MIb before age 55, n (%)f
No 19,473 (88) 20,812 (89) 21,313 (89) 61,598 (89)
Yes 2,546 (12) 2,567 (11) 2,614 (11) 7,727 (11)
Unknown 8,375 7,698 7,317
Emotional well-being
Mean (SD) 72 (16.5) 79.6 (13) 84 (11.6) 78.6 (14.7)
Unknown 533 360 297
Hypertension, n (%)
Never hypertensive 18,812 (63) 20,579 (67) 21,281 (69) 60,672 (67)
Untreated hypertensive 2,762 (9) 2,263 (7) 2,208 (7) 7,233 (8)
Treated hypertensive 8,223 (28) 7,722 (25) 7,265 (24) 23,210 (26)
Unknown 597 513 490
Systolic blood pressure
Mean (SD) 127.5 (18.1) 126.5 (17.9) 126.8 (17.9) 126.9 (18)
Unknown 597 513 490
Treated for high cholesterol, n (%)
No 24,855 (84) 25,994 (85) 26,295 (86) 77,144 (85)
Yes 4,840 (16) 4,442 (15) 4,322 (14) 13,604 (15)
Unknown 699 641 627
Treated for diabetes, n (%)
No 28,674 (95) 29,885 (96) 30,208 (97) 88,767 (96)
Yes 1,676 (6) 1,154 (4) 1,000 (3) 3,830 (4)
Unknown 44 38 36
CHD, coronary heart disease; METS, metabolic equivalent of task; SD, standard deviation.
aIncludes participants with prior cardiovascular disease (CVD) (n¼ 17,351), without prior CVD (n¼ 73,421), and unknown prior CVD status (n¼ 1,943).
bMyocardial infarction.
cCombined with ‘‘other’’ in statistical analyses.
dCombined with $20,000 to $34,999 (most common group) in statistical analyses.
eMetabolic equivalents.
fThis variable was included here for descriptive purposes but not included in analyses because of missing data.
ing
 TABLE 1 (Continued )founders—the HR for incident CHD was 1.04 (95% CI, 0.97,
1.12); for total CVD¼ 1.0 (95% CI, 0.95,1.06); and for all-
cause mortality¼ 1.02 (95% CI, 0.97, 1.07).
TABLE 2. Hazard ratios and 95% confidence intervals for predictPrior CVD Covariates Incident
No (n¼ 73,421) None 0.92 (0.8
Potential confoundersd 0.99 (0.9
Yes (n¼ 17,351) None 0.93 (0.8
Potential confoundersd 1.04 (0.9
CHD, coronary heart disease; CVD, cardiovascular disease.
aNumber of events: Incident CHD (myocardial infarction (MI) or death from CH
bNumber of events: Total CVD (MI, stroke, and/or death from coronary heart d
cardiovascular disease)—2,730 without prior CVD, 1,710 with prior CVD.
cNumber of events: All-cause mortality: 4,030 without prior CVD, 1,999 with p
dPotential confounders: Accounted for sociodemographic characteristics (age, ed
factors (BMI [body mass index], waist/hip ratio, smoking, physical activity, alco
percentage trans-saturated fat intake, percentage sugar intake, and fruit/vegetablhave accounted for most of the attenuation in social support
HRs predicting total CVD, a set of Cox regression analyses
was repeated, including for each model a single covariate in
cardiovascular disease and all-cause mortality from social supportCHDa Total CVDb All-cause Mortalityc
7,0.97) 0.86 (0.83, 0.90) 0.83 (0.81,0.86)
3,1.06) 0.96 (0.92,1.00) 0.95 (0.91,0.98)
8,1.00) 0.91 (0.87,0.95) 0.88 (0.85,0.92)
7,1.12) 1.00 (0.95,1.06) 1.02 (0.97,1.07)
D)—1,210 without prior CVD, 850 with prior CVD.
isease, cerebrovascular disease, possible coronary heart disease, or other
rior CVD.
ucation, race, income, and marital status) and select traditional CVD risk
hol, hormone therapy, age at menopause, percentage saturated fat intake,
e intake).
physiological changes, which would protect her from CVD.TABLE 3. Cox regression hazard ratios for predicting total
cardiovascular disease from social support among participants with
no prior cardiovascular diseasea (n¼ 73,421; cardiovascular
disease events¼ 2,730)
Covariate in model
(in addition to social support)
Hazard ratio for social
support (95% CI)
No covariates 0.87 (0.83,0.89)





Marital status 0.92 (0.88,0.96)
BMI category 0.88 (0.84,0.91)
Waist hip ratio 0.88 (0.84,0.90)
Smoking status 0.87 (0.84,0.91)
Exercise 0.88 (0.85,0.92)
Alcohol use 0.87 (0.83,0.90)
Hormone therapy 0.88 (0.85,0.92)
Early menopause 0.87 (0.84,0.91)
Percentage calories from saturated fatty acids 0.86 (0.83,0.89)
Dietary total trans fatty acid 0.86 (0.82,0.89)
Dietary total sugars 0.85 (0.82,0.89)
Fruits and vegetables 0.86 (0.83,0.89)
BMI, body mass index.
aEach row represents a separate model predicting total cardiovascular disease
(CVD) from social support and the covariate listed in the first column.
the model in addition to social support. Analyses were con-
ducted only in the group that did not report prior CVD at study 
entry. These data serve as an example of which covariates 
influenced the results. As shown in Table 3, the greatest 
attenuation produced by a single covariate occurred in the 
models with income, marital status, and age, in that order.
DISCUSSION
In this large diverse cohort of postmenopausal women from 
across the United States, we found that, in unadjusted analyses, 
higher levels of perceived social support were associated with a 
lower risk of incident CHD, total CVD, and all-cause mortality. 
This conclusion is consistent with other findings in the literature 
based on other populations.11,23,28,36-38 Furthermore, we found 
that higher levels of perceived support were related to lower 
CHD, CVD, and mortality both in women with and without CVD  
at baseline. However, the associations between perceived sup-
port and studied outcomes were not statistically significant after 
controlling for sociodemographic and lifestyle/behavioral fac-
tors, except for mortality in those without prior CVD.
We used a subset of questions from the MOS-SSS, which 
measures perceived functional support, and evaluated this 
subset’s association with CVD and mortality. Other studies 
have used measures of functional support,36-38 but this very 
large cohort study is one of the largest to date to specifically 
study the relationship of perceived social support questions to 
CVD. Previous research has broadly showcased social sup-
port’s association with CVD, but many studies have focused not 
on perceived social support but instead on structural measures 
of support, such as social network ties and integration.19,58 
Perception of support is hypothesized to influence an individ-
ual’s neuroendocrine system and buffer stress.49 Therefore, an 
individual who perceives she has support may be affected byHowever, in this longitudinal study of 10.8 years, we did not
find an association between higher support and less CVD. A
previous study in which adolescent Finns were surveyed on
psychosocial factors and evaluated 27 years later demonstrated
that a positive social environment as an adolescent contributes
to better cardiovascular health.59 We may have captured social
support later in the lifetime of a woman than is relevant to
development of CVD.
Some studies suggest that there may be a minimum thresh-
old of social support,20,60 but our analyses showed a largely
linear association of the scale we used with outcome HRs.
This finding in this large cohort contributes to the theory
regarding perceived support’s influence on CVD and all-
cause mortality.
The potential mechanisms by which perceived social support
influences CVD and other adverse outcomes is complex. There
may be many influences on the outcomes that are difficult to
extrapolate, so it is important to control for variables that may
influence social support, CVD, or both. Social support can
influence behaviors,26 and we controlled for the confounders of
smoking, physical activity, alcohol use, and diet. However, the
relationships on behaviors and support may be bidirectional,
which makes the relationship complex. Although we found that
social support was associated with a reduced risk of CVD
outcomes and death, the findings were nearly completely
eliminated when adding in confounding variables. In addition,
while we controlled for a large number of cardiovascular risk
factors, we acknowledge that not all potential confounders
affecting CVD were controlled for. For example, since the
study was designed and completed, inflammatory markers such
as C-reactive protein and interleukin-6 are more commonly
assessed in studies on CVD. We controlled for family income
while other studies did not.36-38 The large number of covariates
included in our analyses provided more rigorous control for
confounding than in other studies. Other research has demon-
strated social support’s association with MI,37 coronary mor-
bidity,36 and CHD,38 but none of these studies controlled for
income, arguably our strongest confounding variable. Given
our ability to control for a full range of confounders, our
findings call into question prior results.
Women who had prior CVD were analyzed separately from
those without prior CVD. Contrary to earlier reports, we did
not find an association between social support and incident
CHD or total CVD in women with or without prior CVD, but
we did find a small inverse association between perceived
support and all-cause mortality in women without prior CVD,
who were in the majority. This may suggest that social
support’s influence on mortality differs between those with
CVD versus those who are free of CVD; this issue needs
further exploration. In addition, we acknowledge that social
support could be confounded with self-care, in that women
with higher social support have extra support to get to medical
appointments and perform healthy behaviors such as exercise.
Messina et al55 reported that women with higher support were
more likely to access breast cancer screening.
Our study contributes to the literature by showcasing use of to the Pew Research Center, 34% of those older than 65 years
functional support, using perception of support as the mea-
sure. Other studies assessed the relationship of social support
(social ties) with mortality.23,28 Our findings suggest that the
association between perceived social support and CVD in
postmenopausal women is modest and that the confounding
had a small effect on this association. One study evaluating
the association of the psychosocial variables of anger, depres-
sion, and perceived social support found that persons with
anger proneness and with depression had higher chances of
developing peripheral artery disease while followed over 9.7
years.61 However, this same study did not show an association
between low social support and peripheral artery disease. We
found similar in that low social support did not appear to
influence cardiovascular disease, like peripheral artery dis-
ease, another vascular disease. Many studies that show the
association between low support and CVD indicate a trend for
this relationship; however, continued exploration of this topic
is of interest since study findings are conflicting.
Early studies on social support’s effect on CVD were
performed in cohorts that were solely male36,38 while others
investigated both sexes but reported different responses to
social support. In a large Japanese cohort study,43
(n¼ 44,152) low perception of social support was strongly
associated with stroke mortality in men (HR¼ 1.59; 95% CI,
1.01-2.51), but the association was nonsignificant in women.
Another study showed the opposite37—low social support was
associated with increased risk of MI (HR¼ 2.72; 95% CI,
1.42-5.22) and stroke (HR¼ 1.80, 95% CI, 1.05-3.10) in
women but results were nonsignificant in men. In another
large Japanese cohort study,62 researchers studied the psy-
chosocial factor of living in multigenerational households as it
relates to CHD and mortality. Although the Japanese study did
not measure social support, but social interaction, it found that
women living in multigenerational households had two to
three times higher risk of CHD than did women who lived
only with their spouses. Early on, researchers suspected that
there may be sex differences related to the health effects of
social support.21,63 However, many of these studies including
ours were completed more than 10 years ago. We speculate
that when early research was done, men and women had more
traditional roles, and men might have had access to more
support from women than women did from men. In recent
years, the balance has been shifting and men may be giving
support equal to that given by women. It is difficult to project
whether the findings would be true today as traditional roles of
men and women are everchanging. In addition, future studies
should look at support levels in same-sex couples.
The WHI-OS cohort was interviewed at baseline 20 years
ago, and the outcomes were assessed 10 years ago. Because
CVD rates have increased in women in the last few decades,1
a similar study done today may have different results. In
addition, since the initial assessment of social support in this
cohort, online and social media support outlets such as Face-
book have become commonplace, perhaps changing the way
that support is gleaned and assessed by individuals. Accordinguse social media such as Facebook or Twitter.64 However,
recent research shows that, converse to what might be
expected, Facebook may decrease perceived support.65 And
in a study on a Facebook measure of social support, research-
ers found that access to Facebook did not decrease depression
and did not improve quality of life in study participants.66
Further studies my help determine whether online support is a
valid type of social support.
Strengths of our study include the large sample size, the
adjudicated outcomes, and the relative racial/ethnic diversity of
the study sample. Follow-up was extensive, and attempts to
capture missing data were prioritized.51 We controlled for a
large number of confounders which can be seen as a strength of
our study or a limitation as there could have been a flaw in our
theory that the chosen covariates influenced the relationship.
All of these results, including ours, point to the need for
further research on social support and its relation to CVD. Our
large prospective cohort study in women contributes to the
literature by showing that social support’s relationship to
CVD in women needs further clarification, and that there
may be a small, but significant association between social
support and mortality in women who do not have prior CVD.
Study limitations
Participation bias could have influenced the outcomes in that
volunteers in the WHI could have been more healthy or different
than the general population. The WHI researchers made a great
effort to recruit a diverse cohort from across the United States, yet
women who had the time and freedom to participate might have
different characteristics than other women.
Although many potential confounding variables were con-
trolled statistically, some residual confounding is likely. In
particular, measures of inflammation, such as C-reactive
protein and interleukin-6 were not yet seen as risk factors
for CVD when the study was designed.
Social support was captured only at baseline of this study in
which participants were followed for up to 10.8 years. We
were thus unable to account for support at time of outcome or
evaluate any relationship between change in social support,
lifestyle or clinical variables, or outcomes.
In addition, there is no criterion standard for measuring
social support in relation to health outcomes. This study used
a common approach by measuring perceived social support
but did not measure social ties, another common measure
of support.
Most studies relating social support to CVD have assessed
‘‘emotional’’ or ‘‘attachment’’ support,38-40,45 a type of func-
tional perceived support. We assessed emotional/informa-
tional support as well as tangible support, positive social
interaction, and affection using a composite perceived support
scale. We used nine questions from the MOS-SSS which was
developed to assess perceived support in chronically ill
persons,54 and as such might not have been the ideal measure
for our healthy cohort. At least one study which demonstrated
a relationship between social support and CVD assessed
support in a work setting,37 which may indicate that support 11. Berkman LF, Leo-Summers L, Horowitz RI. Emotional support and 
received at work is especially protective against CVD.
We acknowledge that aspects of social well-being such as
having children or being religious could overlap with social
support. We did not include assessment of those measures in
our model.
CONCLUSIONS
This is the largest observational study to date in women to
evaluate perceived social support’s association with CVD and
all-cause mortality. The major finding of our current study is
that although perceived social support may be associated with
fewer cardiovascular outcomes and decreased all-cause
mortality, after controlling for potential confounders, these
associations either become much smaller in magnitude
or disappear.
Our conclusion that perceived social support, a type of
functional support, may be mildly inversely associated with
mortality is important in that it suggests that this is a trend that
needs further clarification and investigation. Future research
should focus on refining measurement of psychological risk
factors such as social support, determining whether there are
sex differences in psychological influences on health, partic-
ularly cardiovascular health, and assessing how psychological
factors can be modified to positively affect health. In
addition, research using, and clarifying between, multiple
measures of social support with longitudinal assessment,
are needed before drawing stronger conclusions about the
causal role of social support in the development or progres-
sion of CVD.
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